Nature Reviews Immunology

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Nature Reviews Immunology

Aug 6, 2024, 16:11 | Insight

Daniel Peeper: Therapeutic approaches combined with PD1 axis blockade to provide synergistic clinical benefit

Daniel Peeper, Head of the Division of Molecular Oncology and Immunology at the Netherlands Cancer…

Aug 4, 2024, 03:58 | Insight

Camilla Engblom: Location goes clonal, immune system style

Camilla Engblom, Assistant Professor at Karolinska Institute, shared on X about a recent paper by…

Aug 1, 2024, 03:50 | Insight

Daniel Peeper: Rational combination of cancer therapies with PD1 axis blockade

Daniel Peeper, Cancer Researcher at The Netherlands Cancer Institute, shared a post on X: “Happy…

All: 3 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023